companies

Hypertrust X-Chain Parent: CAMELOT Consulting Group

Founded 2018
Employees 10+
Primary contact
Gabrielenstraße 9
80636 Munich
Germany
+49 621 86 298 270
Links
https://www.hypertrust-patient.com/
Sections
Technologies
German company CAMELOT developed Hypertrust X-Chain, a patient-centered blockchain solution for pharma and healthcare to ensure the highest level of security for the storage and sharing of patient data for autologous extracorporeal cell treatment. The system's closed-loop supply chain approach removes mistakes throughout the process: from collecting the cells, processing them, transporting them between the stakeholders, and returning the "right cells" to the "right patients." It also makes the relevant patient data available to the stakeholders authorized for the therapy process on the basis of blockchain technology by means of decentralized data storage. In addition, Hypertrust X-Chain enables the flexible integration of partner systems, real-time temperature, location and quality controls as well as security guarantees of origin.
Select partners: SAP, Roche, Körber, CellPoint, Arvato Supply Chain Solutions, Transgene.
Founded 2018
Employees 10+
Primary contact
Gabrielenstraße 9
80636 Munich
Germany
+49 621 86 298 270
Links
https://www.hypertrust-patient.com/
Sections
Technologies

Key people 🧑‍🤝‍🧑

Highlights ⭐

  • Solid management: Andreas Göbel (managing director) has spent more than 15 years in different roles at SAP, while Andreas Gmür (head of strategy) has been advising pharma organizations in supply chain management and logistics. 🔗
  • Modular solution: Hypertrust X-Chain includes different modules which are configurable and scalable to support supply chain needs of different stakeholders. Large pharmaceutical enterprises with an established supply chain infrastructure can leverage Hypertrust X-Chain as a complementary full-service mix-and-match supply chain management solution for Advanced & Personalized Therapies. To small and mid-sized biotech/pharma companies, Hypertrust X-Chain delivers an end-to-end solution out of one hand. It supports central manufacturing, decentralized manufacturing models or even a mixed setup. 🔗
  • Partner network: Even though it's a relatively small startup, Hypertrust (and its parent company CAMELOT Consulting) has managed to score a few big names to test out its blockchain platform.
  • Helps make better therapies: While blockchain holds many promises, only a few companies have managed to make the technology work. Hypertrust is one of those few companies and it's looking to improve transparency in personalized cancer therapies and clinical trials.

Video ▶️

Awards & Recognitions 🏆

  • Selected as one of the top 10 blockchain innovators by the German Ministry of Health 🔗

Quotes 💬

“
We really appreciate Hypertrust Patient Data Care not only delivering results always in time and in highest quality, but also bringing in all their domain expertise to explore and pioneer together with Roche on an use-case of blockchain in personalized healthcare context.
— Ricky Alas, Digital Transformation Lead at Roche 🔗
“
We have set up multiple collaborations around the world to allow each patient's anticancer therapy to be designed in a timely manner. Blockchain technologies are a perfect tool to ensure that the patient's genetic data are protected while ensuring that all the interventions of our partners are both smooth and tracked. We were very happy to collaborate with Hypertrust Patient Data Care and together set up this novel process, demonstrating once again Transgene's ability to be at the forefront of innovation.
— Eric Quéméneur, Pharm.D., Ph.D., Executive VP, Chief Scientific Officer of Transgene 🔗
Last update: August 14, 2022